KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Teladoc Health (TDOC) Depreciation & Amortization (IS) (2016 - 2023)

Teladoc Health's Depreciation & Amortization (IS) history spans 10 years, with the latest figure at $94.3 million for Q3 2023.

  • On a quarterly basis, Depreciation & Amortization (IS) rose 52.08% to $94.3 million in Q3 2023 year-over-year; TTM through Sep 2023 was $315.3 million, a 35.51% increase, with the full-year FY2022 number at $256.0 million, up 25.36% from a year prior.
  • Depreciation & Amortization (IS) hit $94.3 million in Q3 2023 for Teladoc Health, up from $75.5 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (IS) for TDOC hit a ceiling of $94.3 million in Q3 2023 and a floor of $9.6 million in Q1 2019.
  • Historically, Depreciation & Amortization (IS) has averaged $42.5 million across 5 years, with a median of $51.3 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (IS): dropped 1.32% in 2019 and later soared 418.96% in 2021.
  • Tracing TDOC's Depreciation & Amortization (IS) over 5 years: stood at $9.9 million in 2019, then skyrocketed by 273.82% to $37.0 million in 2020, then skyrocketed by 41.59% to $52.3 million in 2021, then skyrocketed by 44.68% to $75.7 million in 2022, then grew by 24.55% to $94.3 million in 2023.
  • Business Quant data shows Depreciation & Amortization (IS) for TDOC at $94.3 million in Q3 2023, $75.5 million in Q2 2023, and $69.8 million in Q1 2023.